What should be done if a patient with a ureteral stent develops blood clots within the stent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Blood Clots Obstructing a Ureteral Stent

If a ureteral stent becomes obstructed with blood clots, immediate intervention with stent removal and replacement or conversion to percutaneous nephrostomy (PCN) is required, particularly if the patient develops fever, flank pain, or signs of sepsis. 1

Immediate Assessment and Diagnostic Work-Up

When a patient with a ureteral stent presents with symptoms suggesting clot obstruction (gross hematuria, flank pain, fever), urgent evaluation is mandatory:

  • Obtain blood cultures (minimum two sets) and urine cultures before any antibiotic changes to identify causative pathogens and guide definitive treatment 1
  • Perform contrast-enhanced CT urogram as first-line imaging to assess stent position/patency, degree of hydronephrosis despite stenting, presence of perinephric stranding or abscess, and any stent-related complications 1
  • Do not delay imaging if clinical status worsens—prompt CT is required to identify correctable anatomic causes such as malpositioned stents, new obstruction, or perinephric collections 1

Urgent Drainage Indications

PCN should be instituted without delay in any patient who is septic, hypotensive, or shows worsening renal function, as PCN provides superior drainage compared to internal stents in infected obstructed systems and improves early and long-term cure rates 1

Specific indications for urgent PCN placement include:

  • Sepsis and/or anuria due to obstructed kidney requires mandatory urgent decompression of the collecting system 1
  • Stent malposition or migration identified on CT 1
  • Severe, persistent hydronephrosis despite stent presence 1
  • Perinephric abscess or pyonephrosis 1
  • Hemodynamically unstable or septic patients may require emergent PCN before imaging if necessary to achieve rapid source control 1

The American College of Radiology specifically recommends PCN for patients with prolonged flank pain, fever, leukocytosis, and dilated collecting system who appear septic 1

Management of Clot Obstruction Without Sepsis

For patients with recurrent gross hematuria and flank pain due to obstructing blood clots but without signs of infection:

  • Ureteral stent placement or replacement can facilitate urinary drainage and resolve clot obstruction 2
  • In a series of patients with major renal trauma who developed recurrent gross hematuria with flank pain, all had obstructing blood clots present at time of stent placement, and urinary extravasation resolved in all patients at a mean of 8 days after stent placement 2
  • Stents should remain indwelling for approximately 4 weeks to ensure resolution of the underlying pathology 2

Antibiotic Management

  • Administer antibiotics immediately if infection is suspected, with regimen adjusted following antibiogram results 1
  • Preprocedural antibiotics are recommended when urosepsis is suspected or known to be present 3
  • Third-generation cephalosporin ceftazidime has shown superiority over fluoroquinolone ciprofloxacin in both clinical and microbiological cure rates 3
  • Continue monitoring until temperature, white-blood-cell count, and inflammatory markers normalize before considering stent removal or further intervention 1

Common Pitfalls to Avoid

  • Do not postpone imaging when clinical status worsens—delaying CT can miss correctable anatomic causes 1
  • Avoid delaying treatment if signs of infection are present, as urosepsis can develop rapidly 1
  • Do not rely on internal stent drainage alone in septic patients—PCN has been shown to improve early and long-term cure rates compared to ureteral stent in cases of infection 1
  • Persistent gross hematuria lasting more than 48-72 hours after stent placement warrants diagnostic evaluation, as it may indicate complications such as obstruction or infection 1

Follow-Up Considerations

  • Intensive care may be necessary in severe cases of sepsis or hemodynamic instability 1
  • After infection control and definitive culture results, tailor antimicrobial therapy to sensitivities 1
  • Follow-up cystography or imaging should confirm resolution of the underlying pathology before stent removal 3

References

Guideline

Treatment of Ureteral Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can a ureteral stent act as a nidus for infection and prolong antibiotic therapy in a patient with an Extended-Spectrum Beta-Lactamase (ESBL) urinary tract infection (UTI)?
Should a Foley catheter (urinary catheter) be removed when a patient has a urinary tract infection (UTI)?
How long after lithotripsy with ureteral stent (double-J stent) placement can a Foley catheter be removed?
Is hematuria and bloody output from the Foley catheter (Foley) and nephrostomy tube expected in a patient with acute kidney injury (AKI) and hyperkalemia after undergoing right nephrostomy tube placement and Foley catheterization (Foley), with reported urethral pressure and minimal clot irrigation?
Should a Foley (indwelling urinary catheter) be replaced in a patient with a urinary tract infection (UTI)?
Can pregnant women be treated with bleomycin?
What is the clinical significance of the neutrophil‑to‑lymphocyte ratio and eosinophil percentage in a patient presenting with pancytopenia?
What is the recommended intravenous dose of nifedipine for an adult with acute severe hypertension?
What causes headache with tadalafil (phosphodiesterase‑5 inhibitor)?
What causes headache with tadalafil?
How should I initially manage a 45‑year‑old man with three days of watery diarrhoea, one day of bloody stool, resolved hypovolaemic shock, mild renal impairment (creatinine 1.67 mg/dL), modest transaminitis (aspartate aminotransferase 60 U/L, alanine aminotransferase 78 U/L) and elevated C‑reactive protein?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.